Cytokines and growth factors regulate growth, differentiation, and activation across lymphocytes, mast cells, endothelial cells, and beyond. This section covers interleukins, interferons, chemokines, the TNF superfamily, colony-stimulating factors, and growth factor families such as TGF-β, VEGF, EGF, and FGF—supporting immunology, cell biology, and drug discovery.
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
Protein structure
| Catalog # | Product / Synonym | Species | Expression | Protein structure |
|---|---|---|---|---|
| BAFFR-MF001 | Mouse | Mouse; HEK293; Recombinant Mouse BAFFR/TNFRSF13C Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Ser10-Ala71 (UniProt accession: Q9D8D0-1). | BAFFR/TNFRSF13CFc N-terminusC-terminus AA segmentSer10-Ala71 | |
| ALK-MF001 | Mouse | Mouse; HEK293; Recombinant Mouse ALK Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Ser19-Cys692 (UniProt accession: P97793). | ALKFc N-terminusC-terminus AA segmentSer19-Cys692 | |
| ACVR1-HF001 | Human | Human; HEK293; Recombinant Human ACVR1/Activin RI Protein is expressed in HEK293 cells with an hFc (IgG1) tag at the C-terminus. It contains amino acid residues Met21-Glu123 (UniProt accession: Q04771). | ACVR1/Activin RIFc N-terminusC-terminus AA segmentMet21-Glu123 | |
| SURVIVIN2B-HP003 | Human | Human; HEK293; Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M) and AYACNTSTL peptide | HLA-A*24:02&B2M&Survivin 2B (AYACNTSTL) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| SSTR2-AB001 | Human | Human; HEK293; Human IgG1-Kappa | Anti-SSTR2Core N-terminusC-terminus | |
| PAR1-HP001 | Human | Recombinant Human Proteinase-activated receptor 1/PAR-1 VLP is expressed from HEK293. It contains Met1-Thr425 (It may have cross reaction with anti-His antibody) (accession: P25116). | Proteinase-activatedHis N-terminusC-terminus AA segmentMet1-Thr425 | |
| MAGEA3-HB003 | Human | Human; HEK293; Gly25-Thr305(HLA-A*24:02), Ile21-Met119(B2M) and IMPKAGLLI peptide | HLA-A*24:02&B2M&MAGE-A3 (IMPKAGLLI) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| MAGEA2-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and KMVELVHFL peptide | HLA-A*02:01&B2M&MAGE-A2 (KMVELVHFL) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| MAGEA1-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and KVLEYVIKV peptide | HLA-A*02:01&B2M&MAGE-A1 (KVLEYVIKV) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| LRRC15-AB001 | Human | Human/Cynomolgus/Rhesus macaque/Mouse; HEK293; Human IgG1-Kappa | Anti-LRRC15Core N-terminusC-terminus | |
| LMP2-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01),Ile21-Met119(B2M)and SSCSSCPLTK peptide | HLA-A*11:01&B2M&LMP2 (SSCSSCPLTK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12V-HB003 | Human | Human; HEK293; Gly25-Thr305 (HLA-A*11:01), Ile21-Met119 (B2M) and VVVGAVGVGK peptide | HLA-A*11:01&B2M&KRAS G12V (VVVGAVGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12D-HP005 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGADGVGK peptide | HLA-A*11:01&B2M&KRAS G12D (VVVGADGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| KRASG12A-HP002 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGAAGVGK peptide | HLA-A*11:01&B2M&KRAS G12A (VVVGAAGVGK) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAC0304-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-C*03:04) & Ile21-Met119(B2M) | Peptide Ready HLA-C*03:04&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAB5701-HB001 | Human | Human; HEK293; Gly25-Ala362(HLA-B*57:01) & Ile21-Met119(B2M) | Peptide Ready HLA-B*57:01&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Ala362 | |
| HLAA6801-HB001 | Human | Human; HEK293; Gly25-Thr305(HLA-A*68:01) & Ile21-Met119(B2M) | Peptide Ready HLA-A*68:01&B2M MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HLAA1101-HB003 | Human | Human; HEK293; Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and AVVGASGVGK peptide | HLA-A*11:01&B2M&RASL11B (AVVGASGVGK) MonomerAviHis N-terminusC-terminus AA segmentGly25-Thr305 | |
| HER3-AB001 | Human | Human/Cynomolgus/Rhesus macaque; HEK293; Human IgG1-Kappa | Anti-Her3Core N-terminusC-terminus | |
| HBV-HP003 | Human | Human; HEK293; Gly25-Thr305 (HLA-A*02:01), Ile21-Met119 (B2M) and FLLTRILTI peptide | HLA-A*02:01&B2M&HBV (FLLTRILTI) TetramerAviHis N-terminusC-terminus AA segmentGly25-Thr305 |
